News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

HuBit Genomix, National Cardiovascular Center To Co-develop Adrenomedullin-Based Drug For Acute Myocardial Infarction Treatment


10/19/2005 5:09:02 PM

Tokyo (JCNN) - Japanese biotech firm HuBit Genomix announced December 13 that it has agreed with the National Cardiovascular Center (NCVC) to collaborate in developing a new agent for the treatment of acute myocardial infarction using adrenomedullin.

Read at JCN Newswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES